Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT06360822
Official study title

Increasing Equity in Lung Cancer Screening

Study summary

The overall objective of this mixed methods study is to: 1) Refine the Emergency Department Lung Cancer Screening (ED-LCS) intervention using qualitative interviews among key stakeholders; 2) pilot test the ED-LCS intervention evaluating the intervention efficacy, acceptability, and feasibility; and 3) provide an in-depth description of stakeholders' experiences with the ED-LCS intervention for future refinement.

Ask AI to explain this study
Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedED-LCS

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 10, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Indiana University

Study sponsor

01
Study overview

What this study is about

Purpose
Health Services Research
Study type
Interventional
Phase
Not applicable
Sponsor
Indiana University
Interventions being studied
Behavioral: ED-LCS
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Eligible for LCS (50-80 years old, smoked in past 15 years, and smoked at least 20 pack years)

Reasons someone may not be able to joinExclusion criteria
  • Non-English/Spanish speaking
  • Decompensated psychiatric illness (suicidal, homicidal, psychosis). Will confirm with attending physicians at time of enrollment
  • Intoxicated with alcohol or drugs
  • Cannot provide reliable follow up contact information (cell phone)
  • Presenting to the ED with a life-threatening condition
  • Have received chest CT scan in past 12 months
  • Already enrolled in LCS
  • Hospice enrolled

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Eskenazi HealthIndianapolis, Indiana

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 10, 2026. Always confirm current availability with the study team.

View original record ↗